Download presentation
Presentation is loading. Please wait.
Published by순창 성 Modified over 5 years ago
1
Does PSA Testing Influence the Natural History of Prostate Cancer?
John Anderson European Urology Supplements Volume 1, Issue 5, Pages 3-10 (August 2002) DOI: /S (02)
2
Fig. 1 Disease-specific mortality by tumour grade in a cohort of 451 men aged 65–75 years at diagnosis and managed conservatively [10] (reproduced with permission). European Urology Supplements 2002 1, 3-10DOI: ( /S (02) )
3
Fig. 2 Trial profile of the Quebec Prostate Cancer Screening Program (man-years [m-y]) [21] (reproduced with permission). European Urology Supplements 2002 1, 3-10DOI: ( /S (02) )
4
Fig. 3 Proportion of men in the ERSPC and PLCO studies with a screening indication for biopsy [23] (reproduced with permission). European Urology Supplements 2002 1, 3-10DOI: ( /S (02) )
5
Fig. 4 Age-adjusted rates of prostate cancer: (a) incidence, and (b) mortality in the SEER Program, 1973–1996. The shaded areas on the figures represent the period following the introduction of PSA testing [24] (reproduced with permission). European Urology Supplements 2002 1, 3-10DOI: ( /S (02) )
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.